CN1247605C - 新型半乳糖苷神经酰胺类似体、使用这些类似体的β－葡糖脑苷酯酶活化剂、皮肤外用药以及β－葡糖脑苷酯酶的活化方法 - Google Patents

新型半乳糖苷神经酰胺类似体、使用这些类似体的β－葡糖脑苷酯酶活化剂、皮肤外用药以及β－葡糖脑苷酯酶的活化方法 Download PDF

Info

Publication number
CN1247605C
CN1247605C CNB028131487A CN02813148A CN1247605C CN 1247605 C CN1247605 C CN 1247605C CN B028131487 A CNB028131487 A CN B028131487A CN 02813148 A CN02813148 A CN 02813148A CN 1247605 C CN1247605 C CN 1247605C
Authority
CN
China
Prior art keywords
glucocerebrosidase
general formula
galactosylceramide
skin
carbons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB028131487A
Other languages
English (en)
Chinese (zh)
Other versions
CN1522263A (zh
Inventor
植松季荣
中岛史雄
吉田雅宏
福永恭子
原真理子
井上绅太郎
西村绅一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Bell Textile Co ltd
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bell Textile Co ltd, Kanebo Ltd filed Critical Bell Textile Co ltd
Publication of CN1522263A publication Critical patent/CN1522263A/zh
Application granted granted Critical
Publication of CN1247605C publication Critical patent/CN1247605C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
CNB028131487A 2001-06-28 2002-06-27 新型半乳糖苷神经酰胺类似体、使用这些类似体的β－葡糖脑苷酯酶活化剂、皮肤外用药以及β－葡糖脑苷酯酶的活化方法 Expired - Lifetime CN1247605C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001196016A JP4070966B2 (ja) 2001-06-28 2001-06-28 新規ガラクトシルセラミド類縁体及び用途
JP196016/2001 2001-06-28

Publications (2)

Publication Number Publication Date
CN1522263A CN1522263A (zh) 2004-08-18
CN1247605C true CN1247605C (zh) 2006-03-29

Family

ID=19033898

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028131487A Expired - Lifetime CN1247605C (zh) 2001-06-28 2002-06-27 新型半乳糖苷神经酰胺类似体、使用这些类似体的β－葡糖脑苷酯酶活化剂、皮肤外用药以及β－葡糖脑苷酯酶的活化方法

Country Status (8)

Country Link
US (2) US7183261B2 (enExample)
EP (1) EP1408045B1 (enExample)
JP (1) JP4070966B2 (enExample)
KR (1) KR100739250B1 (enExample)
CN (1) CN1247605C (enExample)
DE (1) DE60232449D1 (enExample)
TW (2) TWI322151B (enExample)
WO (1) WO2003002584A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101936685B1 (ko) * 2011-11-16 2019-01-11 (주)아모레퍼시픽 글리코실 세라마이드 유사 화합물, 이의 제조방법 및 이를 함유하는 화장료 조성물
JP5918168B2 (ja) * 2012-04-27 2016-05-18 富士フイルム株式会社 β−グルコセレブロシダーゼ活性増強剤
EP2903622A1 (en) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
KR101589633B1 (ko) * 2014-09-18 2016-02-01 한국과학기술연구원 당세라마이드 유도체 및 이의 제조방법
KR102662215B1 (ko) 2014-11-06 2024-05-02 비알 - 알&디 인베스트먼츠, 에스.에이. 치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도
ES2958391T3 (es) 2014-11-06 2024-02-08 Bial R&D Invest S A Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos
US20180185368A1 (en) 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
WO2017027848A1 (en) * 2015-08-12 2017-02-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier
EP3344276B1 (en) 2015-09-03 2020-04-22 The Board of Regents of the University of Oklahoma Peptide inhibitors of clostridium difficile tcdb toxin
KR20230104752A9 (ko) 2016-04-06 2024-11-15 비알 - 알&디 인베스트먼츠, 에스.에이. 피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물및 의학적 장애의 치료에서의 그의 용도
CA3020310A1 (en) 2016-04-06 2017-10-12 Lysosomal Therapeutics Inc. Pyrrolo[1,2-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
US10787454B2 (en) 2016-04-06 2020-09-29 BIAL—BioTech Investments, Inc. Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
JP7164774B2 (ja) 2016-05-05 2022-11-02 ビアル－アール・アンド・ディ・インベストメンツ・ソシエダーデ・アノニマ 置換イミダゾ［１，２－ｂ］ピリダジン、置換イミダゾ［１，５－ｂ］ピリダジン、関連化合物、および医学的障害の治療におけるその使用
EP3452455A4 (en) 2016-05-05 2019-11-13 Lysosomal Therapeutics Inc. SUBSTITUTED IMDAZO [1,2-] PYRIDINES, SUBSTITUTED IMIDAZO [1,2-] PYRAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF ILLNESSES
WO2017207040A1 (en) 2016-06-01 2017-12-07 Vib Vzw ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR
US10933126B2 (en) 2018-05-03 2021-03-02 The Board Of Regents Of The University Of Oklahoma Clostridium difficile immunogenic compositions and methods of use
FR3147951A1 (fr) * 2023-04-19 2024-10-25 Paris Sciences Et Lettres Particules de monosaccharides modifies par une chaine hydrophobe et de cyclodextrine.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07110872B2 (ja) * 1990-09-25 1995-11-29 株式会社ディ・ディ・エス研究所 酸性糖脂質及び微粒子キャリヤー
JP2774417B2 (ja) 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
IT1271624B (it) 1994-03-21 1997-06-04 Lifegroup Spa Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'
JP2896321B2 (ja) * 1994-10-27 1999-05-31 鐘紡株式会社 β−グルコセレブロシダーゼの活性化方法

Also Published As

Publication number Publication date
KR20040048381A (ko) 2004-06-09
JP4070966B2 (ja) 2008-04-02
DE60232449D1 (de) 2009-07-09
TW201002734A (en) 2010-01-16
EP1408045B1 (en) 2009-05-27
WO2003002584A1 (en) 2003-01-09
EP1408045A4 (en) 2005-12-28
JP2003012684A (ja) 2003-01-15
US20070111951A1 (en) 2007-05-17
EP1408045A1 (en) 2004-04-14
CN1522263A (zh) 2004-08-18
US20040242499A1 (en) 2004-12-02
TWI322151B (enExample) 2010-03-21
US7183261B2 (en) 2007-02-27
KR100739250B1 (ko) 2007-07-12
HK1067642A1 (en) 2005-04-15

Similar Documents

Publication Publication Date Title
CN1247605C (zh) 新型半乳糖苷神经酰胺类似体、使用这些类似体的β－葡糖脑苷酯酶活化剂、皮肤外用药以及β－葡糖脑苷酯酶的活化方法
US11744812B2 (en) Methods of treatment
CN109562137A (zh) 用于治疗与异常炎性反应有关的病况的方法和组合物
CA3157861A1 (en) Pharmaceutical formulations comprising niclosamide compound
CN1812795A (zh) 外用组成物
CN1699390A (zh) 新的c－糖苷衍生物及其化妆用途
CN1270509A (zh) 间苯二酚衍生物
KR20150105307A (ko) 비천연 흡습성 아미노산을 함유하는 피부 조성물
CN1305460C (zh) 糖摄取的促进方法
CN104262241B (zh) 5-氨基酮戊酸与3-羟基吡啶-4-酮的缀合物及其制备法和用途
CN1805948A (zh) 抗坏血酸的稳定衍生物
US20230102999A1 (en) Deuterated niclosamide
KR101702076B1 (ko) 지방산 컨쥬게이션된 7-데하이드로콜레스테롤 유도체
CN1839143A (zh) 抗坏血酸衍生物及美白化妆材料
CA1329591C (en) Pharmaceutical products and new lactosyl compounds and the preparation thereof
HK1067642B (en) NOVEL GALACTOSYLCERAMIDE ANALOGS AND β - GLUCOCEREBROSIDASE ACTIVATORS, EXTERNAL SKIN PREPARATIONS AND METHOD OF ACTIVATING β-GLUCOCEREBROSIDASE USING THE ANALOGS
AU2015345943B2 (en) Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
KR101451401B1 (ko) 비타민 c와 비타민 e의 컨쥬게이트 및 그를 포함하는 항산화제
JPH08283150A (ja) 抗炎症剤
EP1272183B1 (en) Methods and compositions useful in enhancing oxygen delivery to cells
CN119143825A (zh) 一种抗衰老的nmn衍生物及其制备工艺和应用
CN119954769A (zh) 一种硫辛酸衍生的神经酰胺及其合成方法和应用
CN1909878A (zh) 皱纹改善剂
HK1028344B (en) Resorcinol derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: KANEBO COSMETICS INC.

Free format text: FORMER OWNER: KANEBO LTD.

Effective date: 20041105

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20041105

Address after: Tokyo, Japan

Applicant after: Bell Textile Co.,Ltd.

Address before: Tokyo, Japan

Applicant before: KANEBO, LTD.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1067642

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20060721

Address after: Tokyo, Japan

Patentee after: KAO Corp.

Address before: Tokyo, Japan

Patentee before: Bell Textile Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20060329

CX01 Expiry of patent term